secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alzamend Neuro, Inc. (ALZN)
CIK:        0001677077
Form:       8-K
Filed at:   2026-07-21T20:30:22+00:00
Accession:  0001214659-26-008772
Event type: leadership
Sentiment:  negative
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alzamend Neuro announces death of director Lynne Fahey McGrath on July 20, 2026
-------------------------------------------------------------------------------

- Dr. Lynne Fahey McGrath, a director of Alzamend Neuro, passed away on July 20, 2026.
- She served on the Board since the company's IPO in June 2021.
- Chairman William B. Horne expressed condolences and highlighted her contributions and insights.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1677077/000121465926008772/0001214659-26-008772-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1677077/000121465926008772/p7202618k.htm
  HTML page:      https://secwatch.observer/filing/0001214659-26-008772

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer